Pfizer Inc. closed 26.70% short of its 52-week high of $31.54, which the company achieved on July 30th.

Investing in stocks based on valuation metrics is considered a smart strategy. The price-to-earnings (P/E) ratio is often the go-to metric due to its simplicity and ease of use. However, the ...

Super-high-yield stocks often deliver heaps of passive income early on, but they aren't famous for rapid payout raises.

Jefferies reaffirms its Buy rating on Pfizer and sticks to a $33 target, calling the stock undervalued at $23.35. Their ...